Check-Cap Ltd (7CC) - Cash Flow Conversion Efficiency

Latest as of December 2023: -0.149x

Based on the latest financial reports, Check-Cap Ltd (7CC) has a cash flow conversion efficiency ratio of -0.149x as of December 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.54 Million ≈ $-4.14 Million USD) by net assets (€23.69 Million ≈ $27.69 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Check-Cap Ltd (7CC) market capitalisation for the company's overall valuation and market capitalisation.

Check-Cap Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Check-Cap Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Check-Cap Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Check-Cap Ltd ranked by their cash flow conversion efficiency. Explore earnings quality score of Check-Cap Ltd to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Solarmax Technology Inc. Common Stock
NASDAQ:SMXT
367.037x
Cabnet Holdings Bhd
KLSE:0191
0.009x
Vivid Games S.A
WAR:VVD
-0.050x
Top Shelf International Holdings Ltd
AU:TSI
-0.324x
Phoenix Motor Inc. Common Stock
NASDAQ:PEV
-0.277x
Prg Holdings Bhd
KLSE:7168
-0.011x
ERG S.A.
WAR:ERG
0.048x
Ucloudlink Group Inc
NASDAQ:UCL
-0.337x

Annual Cash Flow Conversion Efficiency for Check-Cap Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Check-Cap Ltd from 2016 to 2025. View current stock price of Check-Cap Ltd for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €3.44 Million
≈ $4.02 Million
€-46.00K
≈ $-53.78K
-0.013x -100.24%
2024-12-31 €-1.45 Million
≈ $-1.70 Million
€-8.00 Million
≈ $-9.36 Million
5.520x +871.22%
2023-12-31 €23.69 Million
≈ $27.69 Million
€-16.95 Million
≈ $-19.82 Million
-0.716x -58.06%
2022-12-31 €41.31 Million
≈ $48.30 Million
€-18.71 Million
≈ $-21.87 Million
-0.453x -41.13%
2021-12-31 €50.69 Million
≈ $59.26 Million
€-16.26 Million
≈ $-19.01 Million
-0.321x +59.93%
2020-12-31 €16.38 Million
≈ $19.15 Million
€-13.11 Million
≈ $-15.33 Million
-0.801x +61.14%
2019-12-31 €6.23 Million
≈ $7.29 Million
€-12.84 Million
≈ $-15.01 Million
-2.060x -165.41%
2018-12-31 €13.03 Million
≈ $15.23 Million
€-10.11 Million
≈ $-11.82 Million
-0.776x +48.99%
2017-12-31 €5.91 Million
≈ $6.90 Million
€-8.99 Million
≈ $-10.51 Million
-1.522x -99.89%
2016-12-31 €10.41 Million
≈ $12.17 Million
€-7.92 Million
≈ $-9.26 Million
-0.761x --

About Check-Cap Ltd

F:7CC Germany Diagnostics & Research
Market Cap
$48.35 Million
€41.36 Million EUR
Market Cap Rank
#27375 Global
#2352 in Germany
Share Price
€5.35
Change (1 day)
+0.00%
52-Week Range
€0.82 - €7.80
All Time High
€736.32
About

Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology for the detection of precancerous colorectal polyps. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.